CVR - Coronavirus Vaccines R&D Roadmap

overhead image of group of people

The CVR Initiative

CIDRAP and CEPI address the threat of coronaviruses through a comprehensive and coordinated initiative to advance vaccine R&D
vaccine vials

Coronavirus Vaccine Technology Landscape

The Landscape compiles and summarizes publicly available information on the global R&D pipeline of broadly protective, MERS, and SARS-CoV-2 coronavirus vaccine candidates in preclinical and clinical development.

SARS CoV 2

R&D Progress Tracker

The R&D Progress Tracker follows scientific, regulatory, manufacturing, and policymaking activities that, if accomplished, will accelerate the development of broadly protective coronavirus vaccines.

Covid-19

CVR Scholar Hub

The CVR Scholar Hub makes available research that illuminates the virologic and immunologic underpinnings of coronavirus vaccinology, including information on mucosal vs. systemic immunity, broadly conserved epitopes, mucosal biomarkers, and more.

crowd of people

The CVR Initiative

A joint initiative of CIDRAP and CEPI that monitors and evaluates progress towards the development of coronavirus vaccines, creating open-access resources for researchers, developers, and funding organizations.

Funding for the CVR Initiative provided by
Funding for CVR development provided by

The findings and conclusions contained within are those of the authors and do not necessarily reflect the positions or policies of the Bill & Melinda Gates Foundation and The Rockefeller Foundation.